menu toggle

Insights

Perspective, tips, and resources for moving health forward

abstract-brand-colors-texture-2
All Insights Health Systems Pharmacies Physician Practices Manufacturers Animal Health
AmerisourceBergen

Webinar on demand: Implications of the EU JCA on patient access and engagement

Inverted color AmerisourceBergen icon
AmerisourceBergen
November 2023

Manufacturers

Gauge the impact: What does the striking down of a federal copay accumulator regulation mean for patients and copay programs?

Inverted color AmerisourceBergen icon
AmerisourceBergen
October 2023
US capitol color

Manufacturers

First 10 drugs for Medicare price negotiation announced under IRA

Corey Ford
Corey Ford, MHA
August 2023
Washington DC Capital

Manufacturers

The cures conundrum: The importance of getting value assessment right for transformational therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2023
getting value assessment right for transformational therapies

Manufacturers

VPAS—Where next?

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2023
VPAS What's Next

Manufacturers

Multistakeholder perspectives on Joint Clinical Assessment in Europe

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2023
Group Physicians Wearing Masks

Manufacturers

What's next for biopharma under the inflation reduction act

Corey Ford
Corey Ford, MHA
July 2023
Coworkers at meeting

Manufacturers

On-demand webinar: The EU JCA process: Opportunities and challenges in bringing innovative medicines to patients in Europe

Inverted color AmerisourceBergen icon
AmerisourceBergen
June 2023

Manufacturers

New pan-EU HTA: How can biopharma navigate the joint clinical assessment?

Inverted color AmerisourceBergen icon
AmerisourceBergen
January 2023
New Pan-EU HTA

Manufacturers

Maintain an agile copay program in a changing policy environment

AB-TB-Sq-Block
AmerisourceBergen
September 2022
fv-ab-webheader10

Manufacturers

How will the Inflation Reduction Act affect the biopharma industry?

AB-TB-Sq-Block
AmerisourceBergen
August 2022
vaccines on top of US dollars

Manufacturers

Roundtable: Policy and its impact on the pharmaceutical industry

Inverted color AmerisourceBergen icon
AmerisourceBergen
June 2022
policy impacts on pharma

Manufacturers

Mind the (Evidence) Gap

Kim McLeod
Kim McLeod, MPH
Xcenda
February 2020
MindtheGap

Manufacturers

Preparing for DSCSA Interoperability

AB-TB-Sq-Block
Matt Sample
AmerisourceBergen
May 2019

Phase II of DSCSA requires interoperable systems for the electronic tracking of product through the supply chain. Is pharma prepared? Learn what stakeholders need to know and do know to prepare for 2023.

Manufacturers

Managing the Growing Expansion of Copay Accumulators

Corey Ford
Corey Ford, MHA
March 2019

Manufacturers

Moving Medicare Coverage

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2019

Executive Q&A: How shifting coverage for some drugs from Medicare Part B to Part D could impact access and affordability for patients.